Gossamer Bio, Inc.
GOSS
$2.46
-$0.07-2.77%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 16.18% | 5.44% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 16.18% | 5.44% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 16.18% | 5.44% | |||
| SG&A Expenses | 0.24% | -7.84% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.61% | 2.62% | |||
| Operating Income | -5.31% | -1.89% | |||
| Income Before Tax | -4.46% | -3.38% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -4.46% | -10.93% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -4.46% | -10.93% | |||
| EBIT | -5.31% | -1.89% | |||
| EBITDA | -5.31% | -2.18% | |||
| EPS Basic | -4.27% | 44.60% | |||
| Normalized Basic EPS | -4.16% | 62.24% | |||
| EPS Diluted | -5.26% | 44.60% | |||
| Normalized Diluted EPS | -4.16% | 62.24% | |||
| Average Basic Shares Outstanding | 0.20% | 0.09% | |||
| Average Diluted Shares Outstanding | 0.20% | 0.09% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||